Susan Bort

2.8k total citations
10 papers, 340 citations indexed

About

Susan Bort is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Susan Bort has authored 10 papers receiving a total of 340 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 4 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Susan Bort's work include Immune Cell Function and Interaction (7 papers), T-cell and B-cell Immunology (5 papers) and CAR-T cell therapy research (4 papers). Susan Bort is often cited by papers focused on Immune Cell Function and Interaction (7 papers), T-cell and B-cell Immunology (5 papers) and CAR-T cell therapy research (4 papers). Susan Bort collaborates with scholars based in United States, Slovakia and China. Susan Bort's co-authors include David B. Lewis, Randy Q. Cron, David B. Lewis, Ann J. Melvin, Seymour J. Klebanoff, A Clausell, Steven R. Bartz, Mark W. Brunvand, Gregory Dolganov and Yunxia Wang and has published in prestigious journals such as Blood, The Journal of Immunology and Gastroenterology.

In The Last Decade

Susan Bort

8 papers receiving 330 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susan Bort United States 5 238 142 90 39 37 10 340
Tsukasa Koiwa Japan 6 203 0.9× 103 0.7× 74 0.8× 24 0.6× 30 0.8× 8 347
Stephen Soonthornvacharin United States 7 198 0.8× 157 1.1× 67 0.7× 20 0.5× 27 0.7× 8 314
Roberto Orsatti Italy 13 297 1.2× 222 1.6× 67 0.7× 57 1.5× 135 3.6× 21 526
Elisabeth Littwitz-Salomon Germany 11 301 1.3× 85 0.6× 87 1.0× 31 0.8× 96 2.6× 21 411
Florent Colomb United Kingdom 12 207 0.9× 254 1.8× 32 0.4× 27 0.7× 43 1.2× 19 375
Giulia Della Chiara Italy 8 111 0.5× 190 1.3× 107 1.2× 38 1.0× 21 0.6× 11 328
Karine Duperrier France 8 305 1.3× 118 0.8× 41 0.5× 9 0.2× 39 1.1× 10 432
John A. Wrobel United States 9 223 0.9× 252 1.8× 36 0.4× 52 1.3× 87 2.4× 17 468
Simone Joas Germany 6 80 0.3× 56 0.4× 72 0.8× 22 0.6× 22 0.6× 8 180
Nadja Schubert Germany 8 247 1.0× 129 0.9× 57 0.6× 9 0.2× 26 0.7× 10 350

Countries citing papers authored by Susan Bort

Since Specialization
Citations

This map shows the geographic impact of Susan Bort's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan Bort with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan Bort more than expected).

Fields of papers citing papers by Susan Bort

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan Bort. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan Bort. The network helps show where Susan Bort may publish in the future.

Co-authorship network of co-authors of Susan Bort

This figure shows the co-authorship network connecting the top 25 collaborators of Susan Bort. A scholar is included among the top collaborators of Susan Bort based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan Bort. Susan Bort is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Dillon, Stacey R., Lawrence S. Evans, Katherine E. Lewis, et al.. (2021). OP0039 ALPN-303, AN ENHANCED, POTENT DUAL BAFF/APRIL ANTAGONIST ENGINEERED BY DIRECTED EVOLUTION FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) AND OTHER B CELL-RELATED AUTOIMMUNE DISEASES. Annals of the Rheumatic Diseases. 80. 21–21. 3 indexed citations
2.
Levin, Steven D., Lawrence S. Evans, Susan Bort, et al.. (2020). Novel Immunomodulatory Proteins Generated via Directed Evolution of Variant IgSF Domains. Frontiers in Immunology. 10. 3086–3086. 9 indexed citations
3.
4.
Swiderek, Kristine M., Stacey R. Dillon, John W. Moore, et al.. (2020). P156 ALPN-101, A FIRST-IN-CLASS DUAL ICOS/CD28 ANTAGONIST, DEMONSTRATES EFFICACY IN PATIENT-DERIVED PBMC IN VITRO AND IN AN IN VIVO T CELL TRANSFER MODEL OF CHRONIC INFLAMMATORY BOWEL DISEASE (IBD). Inflammatory Bowel Diseases. 26(Supplement_1). S4–S4. 1 indexed citations
5.
Dillon, Stacey R., Katherine E. Lewis, Ryan Swanson, et al.. (2018). A Dual ICOS/CD28 Antagonist ICOSL Variant Ig Domain (vIgD) Potently Suppresses Human Mixed Lymphocyte Reactions and Human/NSG Mouse Xenograft Graft vs. Host Disease (GvHD). Biology of Blood and Marrow Transplantation. 24(3). S187–S188. 2 indexed citations
6.
Bort, Susan, et al.. (2009). Anti-IL-21 monoclonal antibody reduces disease severity and inflammatory cytokines in a murine model of psoriasis and colitis (97.16). The Journal of Immunology. 182(Supplement_1). 97.16–97.16. 1 indexed citations
7.
Cron, Randy Q., Steven R. Bartz, A Clausell, et al.. (2000). NFAT1 Enhances HIV-1 Gene Expression in Primary Human CD4 T Cells. Clinical Immunology. 94(3). 179–191. 106 indexed citations
8.
Cron, Randy Q., Susan Bort, Yunxia Wang, Mark W. Brunvand, & David B. Lewis. (1999). T Cell Priming Enhances IL-4 Gene Expression by Increasing Nuclear Factor of Activated T Cells. The Journal of Immunology. 162(2). 860–870. 47 indexed citations
9.
10.
Melvin, Ann J., et al.. (1995). Hypomethylation of the interferon‐γ gene correlates with its expression by primary T‐lineage cells. European Journal of Immunology. 25(2). 426–430. 93 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tsukasa Koiwa Breakdown of academic impact, for papers by Stephen Soonthornvacharin Breakdown of academic impact, for papers by Roberto Orsatti Breakdown of academic impact, for papers by Elisabeth Littwitz-Salomon Breakdown of academic impact, for papers by Florent Colomb Breakdown of academic impact, for papers by Giulia Della Chiara Breakdown of academic impact, for papers by Karine Duperrier Breakdown of academic impact, for papers by John A. Wrobel Breakdown of academic impact, for papers by Simone Joas Breakdown of academic impact, for papers by Nadja Schubert
Rankless by CCL
2026